SWOT Analysis for Sai Life Science Ltd. - Weakness

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Stock passes majority of CANSLIM Investment criteria

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

High promoter stock pledges

Top Losers

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Rising Delivery Percentage Compared to Prev Day

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks